Essential function of HIPK2 in TGFβ-dependent survival of midbrain dopamine neurons

Nature Neuroscience

Volumn 10, Issue 1, 2007, Pages 77-86

  Zhang, Jiasheng ^a,c   Pho, Vanee ^a,c   Bonasera, Stephen J ^a   Holzmann, Jed ^b   Tang, Amy T ^a,c   Hellmuth, Joanna ^a   Tang, Siuwah ^a,c   Janak, Patricia H ^a   Tecott, Laurence H ^b   Huang, Eric J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DYSTONIA; EMBRYO; FEMALE; GENE ACTIVATION; GENE DELETION; MESENCEPHALON; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PSYCHOMOTOR DISORDER;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BEHAVIOR, ANIMAL; BENZAZEPINES; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE AGONISTS; EMBRYO; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONS; PROTEIN-SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA; TYROSINE 3-MONOOXYGENASE;

EID: 33845889727     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1816     Document Type: Article

References (49)

1. Manji, H.K., Drevets, W.C. & Charney, D.S. The cellular neurobiology of depression. Nat. Med. 7, 541-547 (2001).
2. Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron 39, 889-909 (2003).
3. Jackson-Lewis, V. et al. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J. Comp. Neurol. 424, 476-488 (2000).
4. Oppenheim, R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453-501 (1991).
5. Hyman, C. et al. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14, 335-347 (1994).
6. Hynes, M.A. et al. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37, 144-154 (1994).
7. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. & Collins, F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132 (1993).
8. Farkas, L.M., Dunker, N., Roussa, E., Unsicker, K. & Krieglstein, K. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J. Neurosci. 23, 5178-5186 (2003).
9. Poulsen, K.T. et al. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252 (1994).
10. Airaksinen, M.S. & Saarma, M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383-394 (2002).
11. Chao, M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309 (2003).
12. Barde, Y.A. Trophic factors and neuronal survival. Neuron 2, 1525-1534 (1989).
13. Oo, T.F., Kholodilov, N. & Burke, R.E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J. Neurosci. 23, 5141-5148 (2003).
14. Kholodilov, N. et al. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J. Neurosci. 24, 3136-3146 (2004).
15. Enomoto, H., Heuckeroth, R.O., Golden, J.P., Johnson, E.M. & Milbrandt, J. Development of cranial parasympathetic ganglia requires sequential actions of GDNF and neurturin. Development 127, 4877-4889 (2000).
16. Cacalano, G. et al. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21, 53-62 (1998).
17. Enomoto, H. et al. GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21, 317-324 (1998).
18. Krieglstein, K., Suter-Crazzolara, C., Fischer, W.H. & Unsicker, K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14, 736-742 (1995).
19. Flanders, K.C. et al. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development 113, 183-191 (1991).
20. Unsicker, K., Flanders, K.C., Cissel, D.S., Lafyatis, R. & Sporn, M.B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 44, 613-625 (1991).
21. Massague, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783-2810 (2005).
22. Harada, J. et al. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J. Biol. Chem. 278, 38998-39005 (2003).
23. Wiggins, A.K. et al. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J. Cell Biol. 167, 257-267 (2004).
24. Yamada, T., McGeer, P.L., Baimbridge, K.G. & McGeer, E.G. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 526, 303-307 (1990).
25. Zhou, Q.Y. & Palmiter, R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209 (1995).
26. Szczypka, M.S. et al. Feeding behavior in dopamine-deficient mice. Proc. Natl. Acad. Sci. USA 96, 12138-12143 (1999).
27. Fernagut, P.O., Diguet, E., Labattu, B. & Tison, F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods 113, 123-130 (2002).
28. Lin, A.H. et al. Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. J. Immunol. 175, 547-554 (2005).
29. Kim, Y.H., Choi, C.Y., Lee, S.J., Conti, M.A. & Kim, Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273, 25875-25879 (1998).
30. Kim, Y.H., Choi, C.Y. & Kim, Y. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl. Acad. Sci. USA 96, 12350-12355 (1999).
31. Kaartinen, V. et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11, 415-421 (1995).
32. Proetzel, G. et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11, 409-414 (1995).
33. Brionne, T.C., Tesseur, I., Masliah, E. & Wyss-Coray, T. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133-1145 (2003).
34. Bonyadi, M. et al. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat. Genet. 15, 207-211 (1997).
35. Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
36. Kele, J. et al. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133, 495-505 (2006).
37. Andersson, E., Jensen, J.B., Parmar, M., Guillemot, F. & Bjorklund, A. Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development 133, 507-516 (2006).
38. Lie, D.C. et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci. 22, 6639-6649 (2002).
39. Krieglstein, K. et al. Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat. Neurosci. 3, 1085-1090 (2000).
40. Hofmann, T.G. et al. Regulation of p53 activity by its interaction with homeodomaininteracting protein kinase-2. Nat. Cell Biol. 4, 1-10 (2002).
41. D'Orazi, G. et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4, 11-19 (2002).
42. Gresko, E. et al. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J. 25, 1883-1894 (2006).
43. Roussa, E. et al. Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon. Stem Cells 24, 2120-2129 (2006).
44. Zhang, F., Endo, S., Cleary, L.J., Eskin, A. & Byrne, J.H. Role of transforming growth factor-beta in long-term synaptic facilitation in Aplysia. Science 275, 1318-1320 (1997).
45. Chin, J., Angers, A., Cleary, L.J., Eskin, A. & Byrne, J.H. Transforming growth factor beta1 alters synapsin distribution and modulates synaptic depression in Aplysia. J. Neurosci. 22, RC220 (2002).
46. Rawson, J.M., Lee, M., Kennedy, E.L. & Selleck, S.B. Drosophila neuromuscular synapse assembly and function require the TGF-beta type I receptor saxophone and the transcription factor Mad. J. Neurobiol. 55, 134-150 (2003).
47. Aberle, H. et al. wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila. Neuron 33, 545-558 (2002).
48. McCabe, B.D. et al. Highwire regulates presynaptic BMP signaling essential for synaptic growth. Neuron 41, 891-905 (2004).
49. Marques, G. et al. The Drosophila BMP type II receptor Wishful Thinking regulates neuromuscular synapse morphology and function. Neuron 33, 529-543 (2002).